Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from MedAdvisor Limited ( (AU:MDR) ) is now available.
MedAdvisor Limited has announced the appointment of John Ciccio as its new CEO and Managing Director, succeeding Rick Ratliff who will assist in the transition. Ciccio’s extensive experience with Adheris Health, a US-based business acquired by MedAdvisor, positions him well to lead the company through its next phase of growth. Under Ratliff’s leadership, the company achieved significant milestones, including divesting its ANZ business and completing a major technology transformation. The transition is expected to maintain MedAdvisor’s competitive edge and continue its strategic focus on expanding its health program pipeline and launching a next-generation engagement platform.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.10 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited is a company specializing in pharmacy-driven patient engagement solutions. It focuses on developing technology platforms that enhance patient management and healthcare outcomes, with a significant presence in the US market through its subsidiary, Adheris Health.
Average Trading Volume: 879,399
Technical Sentiment Signal: Sell
Current Market Cap: A$16.45M
For a thorough assessment of MDR stock, go to TipRanks’ Stock Analysis page.